Tiffany Woynaroski is assistant professor of hearing and speech sciences at Vanderbilt University Medical Center, Vanderbilt Kennedy Center, Vanderbilt Brain Institute, and Frist Center for Autism and Innovation in Nashville, Tennessee.
Tiffany Woynaroski
Assistant professor
Vanderbilt University
From this contributor
Common sensory response scores may miss important variations
A person’s “overall” score on sensory-seeking, hyperreactive or hyporeactive tendencies may obscure nuances in their individual sensory experience.
Common sensory response scores may miss important variations
Errors of omission: Why we are deeply concerned about research on autism therapies
Studies of autism treatments rarely report adverse events, and the scientists involved often fail to disclose their conflicts of interest.
Errors of omission: Why we are deeply concerned about research on autism therapies
Explore more from The Transmitter
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.